Guideline-directed medical strategies for the co-management of heart failure and metabolic dysfunction-associated steatotic liver disease
Abstract There is a high and rising global prevalence of people with both metabolic dysfunction-associated steatotic liver disease (MASLD) and heart failure, which has a severe impact, highlighting the need to address these conditions. However, the relationship between MASLD and heart failure remain...
Saved in:
| Main Authors: | Jacob J. Gries, Bing Chen, Meena B. Bansal, Mario Rodriguez, Saleh A. Alqahtani, Paul N. Brennan, Chim C. Lang, W. H. Wilson Tang, Jeffrey V. Lazarus, Chayakrit Krittanawong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Communications Medicine |
| Online Access: | https://doi.org/10.1038/s43856-025-00951-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outcomes of coronary revascularization in patients with metabolic dysfunction-associated steatotic liver disease: a systematic review
by: Jacob J. Gries, et al.
Published: (2025-08-01) -
Evaluating the Relationship Between Gastrointestinal Bleeding and Valvular Heart Disease: A Systematic Review of Clinical Studies
by: Jacob J. Gries, et al.
Published: (2024-12-01) -
A bibliometric analysis of a decade’s research on metabolic dysfunction-associated steatotic liver disease in the Arab world
by: Waleed Alhazzani, et al.
Published: (2025-05-01) -
Trans-ancestral rare variant association study with machine learning-based phenotyping for metabolic dysfunction-associated steatotic liver disease
by: Robert Chen, et al.
Published: (2025-03-01) -
Metabolic dysfunction-associated steatotic liver disease
by: Chieh Chen, et al.
Published: (2024-12-01)